ANO5

anoctamin 5, the group of Anoctamins

Basic information

Region (hg38): 11:21782659-22283567

Previous symbols: [ "TMEM16E", "LGMD2L" ]

Links

ENSG00000171714NCBI:203859OMIM:608662HGNC:27337Uniprot:Q75V66AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive limb-girdle muscular dystrophy type 2L (Limited), mode of inheritance: AR
  • gnathodiaphyseal dysplasia (Supportive), mode of inheritance: AD
  • autosomal recessive limb-girdle muscular dystrophy type 2L (Supportive), mode of inheritance: AR
  • gnathodiaphyseal dysplasia (Moderate), mode of inheritance: AD
  • gnathodiaphyseal dysplasia (Strong), mode of inheritance: AD
  • autosomal recessive limb-girdle muscular dystrophy type 2L (Strong), mode of inheritance: AR
  • Miyoshi muscular dystrophy 3 (Strong), mode of inheritance: AR
  • autosomal recessive limb-girdle muscular dystrophy (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Gnathodiaphyseal dysplasiaADAllergy/Immunology/InfectiousIndividuals have been reported as being frequently affected by osteomyelitis of the jaw, and awareness of the risk may allow early detection and management of lesionsAllergy/Immunology/Infectious; Musculoskeletal5816667; 9673985; 15124103; 17132147; 17008331; 20096397; 20692837; 21186264; 22951575; 21820307; 22402862; 22499103; 23047743

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ANO5 gene.

  • not provided (41 variants)
  • Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L (41 variants)
  • Autosomal recessive limb-girdle muscular dystrophy type 2L (16 variants)
  • Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia (13 variants)
  • Autosomal recessive limb-girdle muscular dystrophy (12 variants)
  • Miyoshi muscular dystrophy 3 (6 variants)
  • ANO5-related disorder (4 variants)
  • Gnathodiaphyseal dysplasia (3 variants)
  • Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L;Miyoshi muscular dystrophy 3 (3 variants)
  • Autosomal recessive limb-girdle muscular dystrophy type 2L;Miyoshi muscular dystrophy 3;Gnathodiaphyseal dysplasia (2 variants)
  • Abnormality of the musculature (2 variants)
  • Lower limb muscle weakness;Elevated circulating creatine kinase concentration;Achilles tendon contracture;Lower limb amyotrophy;Polycystic kidney disease (1 variants)
  • ANO5-related muscular dystrophy (1 variants)
  • Miyoshi muscular dystrophy 3;Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L (1 variants)
  • Miyoshi muscular dystrophy 3;Autosomal recessive limb-girdle muscular dystrophy type 2L (1 variants)
  • Intellectual disability (1 variants)
  • Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia;Miyoshi muscular dystrophy 3 (1 variants)
  • Myopathy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANO5 gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
13
clinvar
115
clinvar
1
clinvar
129
missense
7
clinvar
17
clinvar
478
clinvar
6
clinvar
3
clinvar
511
nonsense
36
clinvar
17
clinvar
1
clinvar
54
start loss
1
1
frameshift
29
clinvar
10
clinvar
4
clinvar
43
splice donor/acceptor (+/-2bp)
6
clinvar
24
clinvar
2
clinvar
32
Total 78 68 499 121 4

Highest pathogenic variant AF is 0.00117807

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ANO5protein_codingprotein_codingENST00000324559 2290182
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.85e-220.31212531834261257470.00171
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1174674740.9850.00002396040
Missense in Polyphen168181.520.925532417
Synonymous-1.801921631.180.000008201635
Loss of Function1.864257.20.7340.00000328657

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002540.00248
Ashkenazi Jewish0.000.00
East Asian0.0003820.000381
Finnish0.0005560.000554
European (Non-Finnish)0.002860.00282
Middle Eastern0.0003820.000381
South Asian0.0004900.000490
Other0.001810.00179

dbNSFP

Source: dbNSFP

Function
FUNCTION: Does not exhibit calcium-activated chloride channel (CaCC) activity. {ECO:0000269|PubMed:20056604, ECO:0000269|PubMed:23047743}.;
Disease
DISEASE: Limb-girdle muscular dystrophy 2L (LGMD2L) [MIM:611307]: An autosomal recessive degenerative myopathy characterized by proximal weakness, weakness of the hip and shoulder girdles and prominent asymmetrical quadriceps femoris and biceps brachii atrophy. {ECO:0000269|PubMed:20096397, ECO:0000269|PubMed:22499103, ECO:0000269|PubMed:25864073, ECO:0000269|PubMed:25891276}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Miyoshi muscular dystrophy 3 (MMD3) [MIM:613319]: A late- onset muscular dystrophy characterized by distal muscle weakness of the lower limbs, calf muscle discomfort and weakness, quadriceps atrophy. Muscle weakness and atrophy may be asymmetric. {ECO:0000269|PubMed:20096397, ECO:0000269|PubMed:22499103}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Stimuli-sensing channels;Ion channel transport;Transport of small molecules (Consensus)

Recessive Scores

pRec
0.117

Intolerance Scores

loftool
0.971
rvis_EVS
0.58
rvis_percentile_EVS
82.34

Haploinsufficiency Scores

pHI
0.110
hipred
N
hipred_score
0.329
ghis
0.486

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.261

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ano5
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; reproductive system phenotype;

Gene ontology

Biological process
chloride transport;ion transmembrane transport
Cellular component
endoplasmic reticulum membrane;plasma membrane;integral component of membrane;vesicle
Molecular function
intracellular calcium activated chloride channel activity;protein dimerization activity